{"nct_id":"NCT05496192","title":"A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer","status":"WITHDRAWN","status_verified_date":"2023-04","start_date":"2023-05-31","start_date_type":"ESTIMATED","primary_completion_date":"2024-06-24","primary_completion_date_type":"ESTIMATED","completion_date":"2026-06-24","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BMY"]}